Holzer Holzer & Fistel, LLC is investigating potential shareholder claims on behalf of investors in Orthofix International N.V., AdCare Health Systems, Inc. and TearLab Corporation. The firm is investigating whether the companies complied with federal securities laws in issuing certain public statements. Investors who purchased stock in any of these companies during the relevant time periods identified below that would like to discuss their legal rights are encouraged to contact Holzer Holzer & Fistel, LLC and its attorneys Michael I. Fistel, Jr., Esq. ( firstname.lastname@example.org) or Marshall P. Dees, Esq. ( email@example.com) via email or via toll-free telephone at (888) 508-6832.
Orthofix International N.V.
On July 29, 2013, Orthofix International (NASDAQ: OFIX) announced that it would be unable to file its quarterly report on Form 10-Q for the quarter ended June 30, 2013 by the deadline of August 9, 2013. The company announced that additional time was needed for its Audit Committee to review revenue recognition issues for prior periods. The price of Orthofix shares fell significantly on the news. The firm’s investigation seeks to determine if statements made between July 26, 2012 and July 29, 2013 relating to the company’s business, prospects and results were misleading to investors at the time they were made.
AdCare Health Systems, Inc.On March 13, 2013, AdCare Health Systems (NYSE: ADK) announced that investors should not rely on its previously issued financial statements for the quarters ended March 31, 2012, June 30, 2012 and September 30, 2012 due to issues relating to the company’s ability to properly account for certain complex transactions. It also announced that the Audit Committee identified material weaknesses with its internal accounting controls. On April 15, 2013, AdCare further announced the resignation of its Chief Financial Officer and stated that it would be delaying the filing of its annual Form 10-K. AdCare’s stock price has declined dramatically in the wake of these announcements and the firm’s investigation seeks to determine if the Company complied with the federal securities laws between January 1, 2012 and July 8, 2013.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts